Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Peripheral Arterial Disease Market From 2025 To 2034?
The peripheral arterial disease market size has shown significant expansion over recent years. It is anticipated to increase from $4.36 billion in 2024 to $4.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.7%. The market’s past growth is primarily due to factors such as innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, and digital health and remote monitoring.
The market for peripheral arterial disease is projected to experience robust expansion over the coming years. This market is anticipated to reach $6.6 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the forecast period include the rise of interdisciplinary care teams, the adoption of minimally invasive interventions, and the increasing emphasis on lifestyle and exercise prescriptions. Key trends anticipated for the forecast period encompass vascular tele-rehabilitation, multimodal pain management strategies, advancements in wound care, and various public health campaigns.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp
Which Factors And Drivers Are Influencing The Peripheral Arterial Disease Market In 2025?
The increasing prevalence of cardiac diseases is propelling the growth of the peripheral arterial disease market. Cardiac disease is a common heart ailment that affects the main blood vessels supplying the heart muscle. Peripheral arterial disease treatment helps cardiac patients by improving blood flow, reducing cardiovascular risk, alleviating symptoms, and enhancing their quality of life. For instance, in December 2023, according to reports published by The Australian Bureau of Statistics (ABS), an Australia-based government agency, in 2022, one in twenty individuals (5.2% or approximately 1.3 million people) were affected by heart, stroke, and vascular diseases. Additionally, in April 2022, the American College of Cardiology, a US-based non-profit medical association, projected that risk factors for ischemic heart disease are anticipated to increase by 30.7% to 29 million by 2025. Therefore, the rising incidence of cardiac diseases is a key driver for the peripheral arterial disease market.
What Are The Primary Types Of Segments Analyzed In The Peripheral Arterial Disease Market?
The peripheral arterial diseasemarket covered in this report is segmented –
1) By Treatment Type: Devices; Catheters; Drugs; Other Types
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By End User: Hospitals; Specialty Clinics; Others End-Users
Subsegments:
1) By Devices: Stents; Balloons; Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters; Balloon Catheters; Guidewires
3) By Drugs: Antiplatelet Agents; Anticoagulants; Vasodilators
4) By Other Types: Surgical Interventions; Lifestyle Modification Programs; Endovascular Therapy
Which Key Trends Are Expected To Influence The Peripheral Arterial Disease Market In The Coming Years?
Leading companies in the peripheral arterial disease market are concentrating on developing innovative medical devices, such as the intravascular lithotripsy (IVL) catheter, to improve treatment effectiveness, enhance patient outcomes, and shorten recovery times for individuals with vascular conditions. An intravascular lithotripsy (IVL) catheter is a medical instrument utilized for addressing calcified arterial blockages by delivering controlled shockwaves to fragment the calcium, thereby aiding in the restoration of blood flow and improving vessel flexibility during procedures like angioplasty. For instance, in September 2024, Shockwave Medical, Inc., a U.S.-based medical technology company, launched the Shockwave E8 peripheral IVL catheter, a medical device designed to treat peripheral arterial disease by providing targeted intravascular lithotripsy, which employs sonic waves to break down calcium deposits in arterial walls. This innovative strategy helps re-establish blood flow while simultaneously minimizing harm to surrounding tissues. The catheter’s advanced engineering permits simpler navigation through complex vascular anatomy, rendering it appropriate for a broad spectrum of patients.
Who Are The Top Performing Companies In The Peripheral Arterial Disease Market In Recent Years?
Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report
How Does The Peripheral Arterial Disease Market Perform Across Key Geographic Regions?
North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Peripheral Arterial Disease Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp
Browse Through More Reports Similar to the Global Peripheral Arterial Disease Market 2025, By The Business Research Company
Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Anemia And Other Blood Disorder Drugs Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model